Pittman D D, Tomkinson K N, Michnick D, Selighsohn U, Kaufman R J
Department of Molecular and Cellular Genetics, Genetics Institute, Cambridge, Massachusetts 02140.
Biochemistry. 1994 Jun 7;33(22):6952-9. doi: 10.1021/bi00188a026.
Factor VIII and factor V function as cofactors in the blood coagulation cascade to accelerate the rate of activation of factor X and prothrombin, respectively. Both cofactors require proteolytic activation by either activated factor X or thrombin for functional activity. Human factor VIII and factor V expressed in mammalian cells are both modified by posttranslational sulfation of tyrosine residues. In the present study, the posttranslational addition of sulfate in factor V expressed in transfected Chinese hamster ovary (CHO) cells was demonstrated by [35S]sulfate incorporation into the thrombin-cleaved 94-kDa heavy chain and the 150-kDa activation peptide. The presence of tyrosine sulfate in recombinant factor V was confirmed by barium hydroxide hydrolysis and two-dimensional thin-layer electrophoresis. The importance of sulfation for factor V secretion and activity was evaluated by characterizing factor V expressed in Chinese hamster ovary cells grown in the presence of sodium chlorate, a potent inhibitor of posttranslational sulfation in intact cells. Increasing concentrations of sodium chlorate inhibited the incorporation of [35S]sulfate into factor V but did not inhibit the synthesis or secretion of factor V. However, the specific activity of factor V secreted in the presence of sodium chlorate was reduced 5-fold. The reduced activity was attributed to (1) slower cleavage and activation by thrombin and (2) a reduced intrinsic activity of factor Va. In contrast, sulfation of factor V did not affect the rate of activation mediated by factor Xa. These results show that sulfation of factor V is required for efficient thrombin activation but not for activation by factor Xa.(ABSTRACT TRUNCATED AT 250 WORDS)
凝血因子VIII和凝血因子V在血液凝固级联反应中作为辅因子,分别加速因子X和凝血酶原的激活速率。这两种辅因子都需要被激活的因子X或凝血酶进行蛋白水解激活才能发挥功能活性。在哺乳动物细胞中表达的人凝血因子VIII和凝血因子V都通过酪氨酸残基的翻译后硫酸化修饰。在本研究中,通过将[35S]硫酸盐掺入凝血酶切割的94 kDa重链和150 kDa激活肽中,证明了在转染的中国仓鼠卵巢(CHO)细胞中表达的凝血因子V的翻译后硫酸盐添加。通过氢氧化钡水解和二维薄层电泳证实了重组凝血因子V中酪氨酸硫酸盐的存在。通过表征在氯酸钠(完整细胞中翻译后硫酸化的有效抑制剂)存在下生长的中国仓鼠卵巢细胞中表达的凝血因子V,评估了硫酸化对凝血因子V分泌和活性的重要性。氯酸钠浓度的增加抑制了[35S]硫酸盐掺入凝血因子V,但没有抑制凝血因子V的合成或分泌。然而,在氯酸钠存在下分泌的凝血因子V的比活性降低了5倍。活性降低归因于:(1)凝血酶切割和激活较慢;(2)凝血因子Va的内在活性降低。相比之下,凝血因子V的硫酸化不影响由因子Xa介导的激活速率。这些结果表明,凝血因子V的硫酸化是有效凝血酶激活所必需的,但不是因子Xa激活所必需的。(摘要截短至250字)